Tuesday, July 12, 2022

Biotech M&A returns as Vertex, Innoviva make buys - Boston Business Journal

With the ViaCyte deal, Vertex will further expand its cell and gene therapy business, which is already central to its growth strategy.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...